Impella RP
Due to the scarcity of data, Impella RP is not approved for acute right ventricular failure caused by massive pulmonary embolism. We describe here the successful use of Impella RP in acute right ventricular failure caused by massive pulmonary embolism to highlight its promising outcome in such an in...
Gespeichert in:
| Veröffentlicht in: | JACC. Case reports 2019-12, Vol.1 (4), p.622-625 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Due to the scarcity of data, Impella RP is not approved for acute right ventricular failure caused by massive pulmonary embolism. We describe here the successful use of Impella RP in acute right ventricular failure caused by massive pulmonary embolism to highlight its promising outcome in such an indication. (Level of Difficulty: Advanced.)
[Display omitted]
Due to the scarcity of data, Impella RP is not approved for acute right ventricular failure caused by massive pulmonary embolism. We describe here the… |
|---|---|
| ISSN: | 2666-0849 2666-0849 |
| DOI: | 10.1016/j.jaccas.2019.09.009 |